Weakness

differentiate among certain acute disorders, such as acute demyelinating neuropathy (eg, Guillain-Barr√© syndrome), acute botulism, and other acute neuromuscular junction disorders. If myopathy is suspected (suggested by muscle weakness, muscle cramping, and pain), muscle enzymes (eg, creatine kinase [CK], aldolase, lactic dehydrogenase [LDH]) may be measured. Elevated levels are consistent with myopathy but can also be high in neuropathies (reflecting muscle atrophy) and very high in ischemic rhabdomyolysis. Also, levels may not be high in all myopathies. Regular crack cocaine use can also cause chronically moderately elevated CK levels (mean value, 400 IU/L). Clinicians can use MRI to identify muscle inflammation, as occurs in inflammatory myopathies. Muscle biopsy may be necessary ultimately to diagnose myopathy or myositis. MRI or electromyography can help find a suitable site for muscle biopsy. However, needlestick artifact can mimic muscle pathology and must be avoided; thus, biopsy should never be done in the same muscle tested by electromyography. Genetic testing can help confirm certain hereditary myopathies. If motor neuron disorders (eg, ALS) are suspected, tests include electromyography and nerve conduction studies to confirm the diagnosis and exclude treatable disorders that mimic motor neuron disorders (eg, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy with conduction block).
